Augmentation Of Partial ACL Tear: Early Results
Launched by ASSIUT UNIVERSITY · May 21, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called ACL augmentation for people who have a partial tear in their ACL, which is a key ligament in the knee that helps keep it stable. The goal is to see how well this treatment works for patients with this specific type of knee injury. The study is currently looking for participants between the ages of 15 and 50 who have a partial ACL tear but do not have other ligament injuries. It includes people with or without a meniscus tear (another knee injury) and those with recent or older injuries.
If you join the trial, you'll be part of a clinical evaluation to understand how the ACL augmentation helps your knee heal and function better. It’s important to know that people with a complete ACL tear, multiple knee ligament injuries, or who have had unsuccessful ACL surgery before are not eligible. This study is open to all genders and aims to find early results about the benefits and safety of this treatment for partial ACL tears.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age from 15 to 50 years old
- • Partial ACL tear without any other ligament injury
- • with and without meniscal tear
- • with and without knee deformity
- • recent and chronic injury
- Exclusion Criteria:
- • younger than 15 and older than 50 y
- • multiligament injury
- • complete ACL tear
- • failed ACL reconstruction or repair
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Trial Officials
Mohamed Abd-El Radi, Lecturer
Study Director
Orthopaedic Department , Faculty of medicine, Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials